IPA logo

ImmunoPrecise Antibodies (IPA) Working Capital

IPA Annual Working Capital

$2.46 M
-$5.50 M-69.09%

30 April 2024

IPA Working Capital Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

IPA Quarterly Working Capital

$66.90 K
+$178.10 K+160.16%

31 October 2024

IPA Quarterly Working Capital Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

IPA Working Capital Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-69.1%+160.2%
3 y3 years-92.9%+160.2%
5 y5 years+144.8%+160.2%

IPA Working Capital High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-92.9%at low-99.8%+160.2%
5 y5-year-92.9%+1591.2%-99.8%+140.6%
alltimeall time-92.9%+777.6%-99.8%+118.4%

ImmunoPrecise Antibodies Working Capital History

DateAnnualQuarterly
Oct 2024
-
$66.90 K(-160.2%)
July 2024
-
-$111.20 K(-104.5%)
Apr 2024
$2.46 M(-69.1%)
$2.46 M(-44.8%)
Jan 2024
-
$4.45 M(-21.7%)
Oct 2023
-
$5.69 M(-18.9%)
July 2023
-
$7.02 M(-11.9%)
Apr 2023
$7.96 M(-63.4%)
$7.96 M(-12.8%)
Jan 2023
-
$9.13 M(-19.2%)
Oct 2022
-
$11.30 M(-32.6%)
July 2022
-
$16.76 M(-23.0%)
Apr 2022
$21.77 M(-37.5%)
$21.77 M(-16.9%)
Jan 2022
-
$26.19 M(-10.9%)
Oct 2021
-
$29.38 M(-8.8%)
July 2021
-
$32.22 M(-7.5%)
Apr 2021
$34.85 M(<-9900.0%)
$34.85 M(+158.2%)
Jan 2021
-
$13.50 M(+11.3%)
Oct 2020
-
$12.12 M(+201.4%)
July 2020
-
$4.02 M(-2537.8%)
Apr 2020
-$165.00 K(-116.4%)
-$165.00 K(-119.1%)
Jan 2020
-
$862.80 K(+41.4%)
Oct 2019
-
$610.10 K(-43.3%)
July 2019
-
$1.08 M(+7.0%)
Apr 2019
$1.00 M(+159.0%)
$1.00 M(-81.1%)
Jan 2019
-
$5.32 M(-14.7%)
Oct 2018
-
$6.24 M(+1374.0%)
July 2018
-
$423.40 K(+9.1%)
Apr 2018
$388.00 K(-78.4%)
$388.00 K(-76.8%)
Jan 2018
-
$1.67 M(-36.3%)
Oct 2017
-
$2.63 M(+95.8%)
July 2017
-
$1.34 M(-25.2%)
Apr 2017
$1.80 M(-1127.0%)
$1.80 M(-30.3%)
Jan 2017
-
$2.57 M(+1118.9%)
Sept 2016
-
$211.20 K(-224.3%)
June 2016
-
-$169.90 K(-6.4%)
Mar 2016
-
-$181.60 K(+3.9%)
Dec 2015
-$174.80 K(-4.1%)
-
Dec 2015
-
-$174.80 K(+5.6%)
Sept 2015
-
-$165.60 K(-2.5%)
June 2015
-
-$169.90 K(-1.1%)
Mar 2015
-
-$171.80 K(-5.7%)
Dec 2014
-$182.20 K(+17.4%)
-
Dec 2014
-
-$182.20 K(-8.6%)
Sept 2014
-
-$199.30 K(+12.2%)
June 2014
-
-$177.70 K(+21.4%)
Mar 2014
-
-$146.40 K(-5.7%)
Dec 2013
-$155.20 K(-30.2%)
-
Dec 2013
-
-$155.20 K(+50.0%)
Sept 2013
-
-$103.50 K(-57.5%)
June 2013
-
-$243.60 K(+4.6%)
Mar 2013
-
-$232.90 K(+4.8%)
Dec 2012
-$222.20 K(+79.2%)
-
Dec 2012
-
-$222.20 K(+28.4%)
Sept 2012
-
-$173.00 K(+17.2%)
June 2012
-
-$147.60 K(+10.9%)
Mar 2012
-
-$133.10 K(+7.3%)
Dec 2011
-$124.00 K(-182.1%)
-
Dec 2011
-
-$124.00 K(+52.3%)
Sept 2011
-
-$81.40 K(-554.7%)
June 2011
-
$17.90 K(-85.4%)
Mar 2011
-
$122.50 K(-18.9%)
Dec 2010
$151.10 K
-
DateAnnualQuarterly
Dec 2010
-
$151.10 K(-214.9%)
Sept 2010
-
-$131.50 K(+120.6%)
June 2010
-
-$59.60 K(+338.2%)
Mar 2010
-
-$13.60 K(-129.0%)
Dec 2009
$46.90 K(-90.2%)
-
Dec 2009
-
$46.90 K(-63.4%)
Sept 2009
-
$128.00 K(-21.0%)
June 2009
-
$162.10 K(-25.8%)
Mar 2009
-
$218.50 K(-54.6%)
Dec 2008
$480.80 K(+4.5%)
-
Dec 2008
-
$480.80 K(-51.4%)
Sept 2008
-
$989.00 K(+364.8%)
June 2008
-
$212.80 K(-29.1%)
Mar 2008
-
$300.00 K(-34.8%)
Dec 2007
$460.10 K(+980.0%)
-
Dec 2007
-
$460.10 K(+8.8%)
Sept 2007
-
$422.70 K(+24.8%)
June 2007
-
$338.70 K(+1439.5%)
Mar 2007
-
$22.00 K(-48.4%)
Dec 2006
$42.60 K(-90.9%)
-
Dec 2006
-
$42.60 K(-92.9%)
Sept 2006
-
$603.10 K(-64.2%)
June 2006
-
$1.68 M(+346.2%)
Mar 2006
-
$377.40 K(-19.7%)
Dec 2005
$470.00 K(-77.6%)
-
Dec 2005
-
$470.00 K(-23.1%)
Sept 2005
-
$611.00 K(-57.8%)
June 2005
-
$1.45 M(-24.5%)
Mar 2005
-
$1.92 M(-8.6%)
Dec 2004
$2.10 M(+338.2%)
-
Dec 2004
-
$2.10 M(+272.7%)
Sept 2004
-
$563.30 K(-30.9%)
June 2004
-
$815.30 K(-9.1%)
Mar 2004
-
$896.60 K(+87.1%)
Dec 2003
$479.10 K(+4597.1%)
-
Dec 2003
-
$479.10 K(+79.2%)
Sept 2003
-
$267.40 K(<-9900.0%)
June 2003
-
-$1400.00(-103.5%)
Mar 2003
-
$40.30 K(+295.1%)
Dec 2002
$10.20 K(-111.8%)
-
Dec 2002
-
$10.20 K(-66.1%)
Sept 2002
-
$30.10 K(-43.8%)
June 2002
-
$53.60 K(-142.4%)
Mar 2002
-
-$126.40 K(+46.3%)
Dec 2001
-$86.40 K(-76.2%)
-
Dec 2001
-
-$86.40 K(-7.7%)
Sept 2001
-
-$93.60 K(-577.6%)
June 2001
-
$19.60 K(-105.9%)
Mar 2001
-
-$333.40 K(-8.2%)
Dec 2000
-$363.10 K(-282.7%)
-
Dec 2000
-
-$363.10 K(-670.9%)
Sept 2000
-
$63.60 K(-54.4%)
June 2000
-
$139.40 K(-17.1%)
Mar 2000
-
$168.10 K(-15.4%)
Dec 1999
$198.70 K(-35.1%)
-
Dec 1999
-
$198.70 K(-35.1%)
Dec 1998
$306.10 K(-57.9%)
-
Dec 1998
-
$306.10 K(-57.9%)
Dec 1997
$727.80 K(-57.6%)
-
Dec 1997
-
$727.80 K
Dec 1996
$1.72 M
-

FAQ

  • What is ImmunoPrecise Antibodies annual working capital?
  • What is the all time high annual working capital for ImmunoPrecise Antibodies?
  • What is ImmunoPrecise Antibodies annual working capital year-on-year change?
  • What is ImmunoPrecise Antibodies quarterly working capital?
  • What is the all time high quarterly working capital for ImmunoPrecise Antibodies?
  • What is ImmunoPrecise Antibodies quarterly working capital year-on-year change?

What is ImmunoPrecise Antibodies annual working capital?

The current annual working capital of IPA is $2.46 M

What is the all time high annual working capital for ImmunoPrecise Antibodies?

ImmunoPrecise Antibodies all-time high annual working capital is $34.85 M

What is ImmunoPrecise Antibodies annual working capital year-on-year change?

Over the past year, IPA annual working capital has changed by -$5.50 M (-69.09%)

What is ImmunoPrecise Antibodies quarterly working capital?

The current quarterly working capital of IPA is $66.90 K

What is the all time high quarterly working capital for ImmunoPrecise Antibodies?

ImmunoPrecise Antibodies all-time high quarterly working capital is $34.85 M

What is ImmunoPrecise Antibodies quarterly working capital year-on-year change?

Over the past year, IPA quarterly working capital has changed by +$178.10 K (+160.16%)